Australia markets closed

Aytu BioPharma, Inc. (0A8M.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
2.8000-0.0017 (-0.06%)
At close: 06:34PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) -1.26
52-week change 339.61%
S&P500 52-week change 322.36%
52-week high 33.5000
52-week low 31.4000
50-day moving average 32.8565
200-day moving average 32.4514

Share statistics

Avg vol (3-month) 3623
Avg vol (10-day) 3200
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 83.8M
% held by insiders 13.49%
% held by institutions 131.78%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 20.05:1
Last split date 306 Jan 2023

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -18.27%
Operating margin (ttm)10.31%

Management effectiveness

Return on assets (ttm)-2.58%
Return on equity (ttm)-45.75%

Income statement

Revenue (ttm)98.5M
Revenue per share (ttm)21.04
Quarterly revenue growth (yoy)-12.70%
Gross profit (ttm)N/A
EBITDA 3.09M
Net income avi to common (ttm)-18M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)19.53M
Total cash per share (mrq)3.51
Total debt (mrq)18.26M
Total debt/equity (mrq)55.57%
Current ratio (mrq)1.11
Book value per share (mrq)5.90

Cash flow statement

Operating cash flow (ttm)6.11M
Levered free cash flow (ttm)11.39M